FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/02/012156 [Registered on: 26/02/2018] Trial Registered Prospectively
Last Modified On: 12/07/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Study to Understand the Effect of Ayurvedic Management of Urinary Tract Infection 
Scientific Title of Study   Evaluation of Ayurvedic Management of Uncomplicated Urinary Tract Infections In Adult Females– Using Modern Biochemical Tests -A Pre-post,Pragmatic Clinical Study 
Trial Acronym  UTI Study 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neelambika GB 
Designation  Surgical Registrar 
Affiliation  Institute of Ayurveda and Integrative Medicine 
Address  Institute of Ayurveda and Integrative Medicine No.74by2,Jarakabandekaval,Post Attur,Via Yelahanka,Bangalore

Bangalore
KARNATAKA
560064
India 
Phone  08028567310  
Fax    
Email  neelambika@iaimhealthcare.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neelambika GB 
Designation  Surgical Registrar 
Affiliation  Institute of Ayurveda and Integrative Medicine 
Address  Institute of Ayurveda and Integrative Medicine No.74by2,Jarakabandekaval,Post Attur,Via Yelahanka,Bangalore

Bangalore
KARNATAKA
560064
India 
Phone  08028567310  
Fax    
Email  neelambika@iaimhealthcare.org  
 
Details of Contact Person
Public Query
 
Name  Dr Neelambika GB 
Designation  Surgical Registrar 
Affiliation  Institute of Ayurveda and Integrative Medicine 
Address  Institute of Ayurveda and Integrative Medicine No.74by2,Jarakabandekaval,Post Attur,Via Yelahanka,Bangalore

Bangalore
KARNATAKA
560064
India 
Phone  08028567310  
Fax    
Email  neelambika@iaimhealthcare.org  
 
Source of Monetary or Material Support  
Foundation of Revitalization of Local Health Traditions Trust, 74/2, Jarakbande Kaval, Post Attur, Via Yelahanka, Bengaluru, Karnataka 560064 
 
Primary Sponsor  
Name  FRLHT Trust 
Address  74/2, Jarakabande kaval, Attur post, Ramagondanahalli, Karnataka 560064 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neelambika GB  Institute of Ayurveda and Integrative Medicine  Clinical research department, First floor, 74/2, Jarakabande kaval, Attur post, Ramagondanahalli, Karnataka 560064
Bangalore
KARNATAKA 
8095459122

neelambika@iaimhealthcare.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe for Human Research, Institute of Transdisciplinary Health Sciences and Technology  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Adult female 18 to 59 years with diagnosed Urinary tract infection, (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Evaluation of Ayurvedic Management of Uncomplicated Urinary Tract Infections In Adult Females– Using Modern Biochemical Tests -A Pre-post,Pragmatic Clinical Study-[UTI Study]   Based on the Ayurveda assessment of the patient combination of medications from the below mentioned will be prescribed: Punarnavaadi Kashayam, Thrinapanchamoola kashaya, Chandanoshiradi kashayam, Varanadi kashayam, Gokshuradiguggulu, Chandraprabhavati, Tab Cystone, Punarnava + Gokshura Paneeya, Combination of Churna+(Gokshura churna50gms+Manjishtachurna50gms+Yavakshara10gms+Hazralyahooda bhasma10gms)+ Panchavalkala kashayam (with or without tankana bhasma) + Usheerasava + Chandanasava + Saarivadyasava Dosage of the drugs: Based on the assessment the patient combination of drugs appropriate for patient will be selected as per the guidelines of the classical Ayurveda text.No deviation from the classical texts will be done with respect to dosage and medication Route of administration : Oral Duration of therapy : 60 days.  
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  59.00 Year(s)
Gender  Female 
Details  a.Female patients with clinical symptoms of UTI (frequency, urgency, burning micturition/dysuria, foul smelling urine, lower abdomen pain) aged between 18-59 years old.

b.Positive for pus cells(>6) along with Culture yielding >1000 CFU.

c.Patients who had not taken antimicrobials within the last 4 weeks.
 
 
ExclusionCriteria 
Details  a.Upper UTI
b.Complicated cases of UTI such as Anatomical and physiological anomalies in urinary tract, any underline disease such as Calculi, impaired kidney function, Pyelonephritis, Diabetes mellitus etc.
c.Pregnant or nursing mother
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary
1.Reduction in number and severity of symptoms.
2.Reduction in number of pus cells- Pyuria- in urine
3.Reduction of Bacterial colony count.
 
60 days 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in inflammatory markers - CRP and ESR  60 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="47" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/03/2018 
Date of Study Completion (India) 01/11/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Study results will be published in peer reviewed journal and all rights of publications related to this study are with FRLHT. The sponsor has no conflict of interest. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  

Introduction:

Urinary tract infections (UTIs) are one of the most common bacterial infections and a severe public health problem affecting 150 million people each year worldwide. Antibiotics are drug of choice to treat bacterial UTIs. Due to increasing incidence of antibiotic resistance,  preventative approaches such as immune-modulation along with antimicrobial activity need to be encouraged more vigorously. Ayurvedic medicines/ herbs indicated in the texts have shown their efficacy in preventive care/ immune-modulation/ antimicrobial activity through the clinical studies, hence promising alternative of treating or reducing such infections. This exploration encourages us to evident Ayurvedic management for UTI through a defined clinical study. Ayurvedic drugs that would be used in the current study are being used in routine clinical practice and no known adverse reaction has been reported.

Aim: To determine the efficacy of Classical Ayurvedic Management of uncomplicated UTI in adult females

Single arm, Open labeled, non – randomized, pre-post clinical study     

Total duration of clinical study is 18 months

Time point of data collection

1.      Visit 1 - Baseline visit

2.      Visit 2(15th day),3(at 30th day) and4(60th day) – Treatment and follow-up

3.      Visit 5(120th day- it could be a telephonic interview-site visit is not mandatory) – Follow-up

Primary end point of Study

1.      Reduction in number and severity of symptoms.

2.      Reduction in number of pus cells- Pyuria- in urine

3.      Reduction of Bacterial colony count.

Inclusion criteria

a.    Female patients with clinical symptoms of UTI (frequency, urgency, burning micturition/dysuria, foul smelling urine, lower abdomen pain) aged between 18-59 years old

b.    Positive for pus cells(>6) along with Culture yielding >1000 CFU

c.    Patients who had not taken antimicrobials within the last 4 weeks

Exclusion criteria

a.         Upper UTI

b.        Complicated cases of UTI such as Anatomical and physiological anomalies in urinary tract, any underline disease such as Calculi, impaired kidney function, Pyelonephritis, Diabetes mellitus etc.

c.         Pregnant or nursing mother

 

Efficacy/ effect Parameters

Clinical symptoms and laboratory findings will be indicator of efficacy. Assessment will be made on following criteria during follow-up:

1.         Changes in clinical symptoms

2.         Bacterial colony count on urine culture

3.         Changes in number of pus cells, ESR and CRP

 

Benefit of study:

This study will provide documentary proof of the efficacy of Ayurvedic management of UTI. Positive study results could make a big contribution for the society by reducing-

1.         Unnecessary use of antibiotic that would lead to antibiotic resistance

2.         Adverse effects due to repeated antibiotic usage

3.         Burden of infection

4.         Healthcare expenses


 
Close